Paris, October 27, 2008 – CARMAT SAS is an innovative medtech start-up that has just been created and financed by TRUFFLE CAPITAL (http://www.truffle.com), EADS (http://www.eads.com) and the Fondation Alain Carpentier, with additional funding from the French state innovation agency OSEO (http://www.oseo.fr). The company has been spun out of the collaboration between the renowned surgeon Professor Carpentier and EADS on implementation of biomaterials and cutting-edge technologies in the construction of an artificial heart. CARMAT intends to market a fully implantable artificial heart that will be able to provide renewed hope and quality of life to the hundreds of thousands of patients suffering in the aftermath of a massive heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.
ALIZE RP CEO + 33 6 64 18 99 59 + 33 141 22 07 31
69 rue d’Aguesseau 92 100 Boulogne
